12-113844700-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016196.4(RBM19):āc.2753C>Gā(p.Ala918Gly) variant causes a missense change. The variant allele was found at a frequency of 0.00000496 in 1,612,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000020 ( 0 hom., cov: 33)
Exomes š: 0.0000034 ( 0 hom. )
Consequence
RBM19
NM_016196.4 missense
NM_016196.4 missense
Scores
1
2
16
Clinical Significance
Conservation
PhyloP100: 5.26
Genes affected
RBM19 (HGNC:29098): (RNA binding motif protein 19) This gene encodes a nucleolar protein that contains six RNA-binding motifs. The encoded protein may be involved in regulating ribosome biogenesis. Multiple alternatively spliced variants, encoding the same protein, have been identified.[provided by RefSeq, Apr 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.12574777).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM19 | NM_016196.4 | c.2753C>G | p.Ala918Gly | missense_variant | 23/24 | ENST00000261741.10 | NP_057280.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RBM19 | ENST00000261741.10 | c.2753C>G | p.Ala918Gly | missense_variant | 23/24 | 1 | NM_016196.4 | ENSP00000261741.5 | ||
RBM19 | ENST00000392561.7 | c.2753C>G | p.Ala918Gly | missense_variant | 23/25 | 1 | ENSP00000376344.3 | |||
RBM19 | ENST00000545145.6 | c.2753C>G | p.Ala918Gly | missense_variant | 23/25 | 2 | ENSP00000442053.2 | |||
RBM19 | ENST00000552384.1 | n.203C>G | non_coding_transcript_exon_variant | 2/4 | 3 | ENSP00000449604.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152236Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
3
AN:
152236
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 247484Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134022
GnomAD3 exomes
AF:
AC:
3
AN:
247484
Hom.:
AF XY:
AC XY:
2
AN XY:
134022
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000342 AC: 5AN: 1460332Hom.: 0 Cov.: 33 AF XY: 0.00000413 AC XY: 3AN XY: 726398
GnomAD4 exome
AF:
AC:
5
AN:
1460332
Hom.:
Cov.:
33
AF XY:
AC XY:
3
AN XY:
726398
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152354Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74492
GnomAD4 genome
AF:
AC:
3
AN:
152354
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 07, 2024 | The c.2753C>G (p.A918G) alteration is located in exon 23 (coding exon 23) of the RBM19 gene. This alteration results from a C to G substitution at nucleotide position 2753, causing the alanine (A) at amino acid position 918 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;.;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;T
Polyphen
B;B;B
Vest4
MutPred
Gain of catalytic residue at V914 (P = 0.0226);Gain of catalytic residue at V914 (P = 0.0226);Gain of catalytic residue at V914 (P = 0.0226);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at